Schedule 13G ownership disclosure

ADURO BIOTECH, INC.

Security class unavailable · CUSIP: 00739L101

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,200,000
Percent of class
4.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001170316-20-000001
Form type
SC 13G/A
Filer
CHINOOK THERAPEUTICS, INC.
CIK
CIK 1435049
Filed
Jan 17, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub